-Taxation of biopharmaceutical companies -U.S. policy with respect to China
-U.S. policy with respect to Canada
-U.S. Trans-Atlantic Trade and Investment Partnership
-U.S. Trans-Pacific Partnership -Sequestration of FDA fees -H.R.3091,"MODDERN Cures Act of 2013" (all provisions)
-Implementation of Affordable Care Act
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark BUD - Budget/Appropriations HCR - Health Issues
24 - Commerce, Dept of (DOC) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 22 - U.S. Trade Representative (USTR) 24 - Commerce, Dept of (DOC) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 22 - U.S. Trade Representative (USTR) 24 - Commerce, Dept of (DOC) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 22 - U.S. Trade Representative (USTR) 24 - Commerce, Dept of (DOC) 2 - HOUSE OF REPRESENTATIVES 113 - Patent & Trademark Office (PTO) 22 - U.S. Trade Representative (USTR)
CELGENE CORPORATION
86 Morris Ave, Summit, NJ, 07901, US
RICHARD T GIRARDS RICHARD T GIRARDS RICHARD T GIRARDS RICHARD T GIRARDS